Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU).

Randall Severance,Howard I. Schwartz,Ron Dagan,Laurie Connor,Jianing Li,Alison Pedley,Jonathan Hartzel,Tina M. Sterling,Katrina M. Nolan,Gretchen M. Tamms,Luwy Musey,Ulrike K. Buchwald

Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU).

2021

Randall Severance
Howard I. Schwartz
Ron Dagan
Laurie Connor
Jianing Li
Alison Pedley
Jonathan Hartzel
Tina M. Sterling
Katrina M. Nolan
Gretchen M. Tamms
Luwy Musey
Ulrike K. Buchwald

Streptococcus pneumoniae and influenza viruses are associated with significant morbidity and mortality in older adults. Concomitant vaccination against these agents reduces hospitalization and mort...

Keywords:

Immunology
safety tolerability
Influenza vaccine
Vaccination
Pneumococcal conjugate vaccine
Streptococcus pneumoniae
Immunogenicity
Medicine
Concomitant

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations